Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Drug Resistance

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    January 2025
  1. GUGLIELMETTI L, Khan U, Velasquez GE, Gouillou M, et al
    Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
    N Engl J Med. 2025;392:468-482.
    PubMed     Abstract available


    August 2024
  2. O'BRIEN KS, Arzika AM, Amza A, Maliki R, et al
    Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial.
    N Engl J Med. 2024;391:699-709.
    PubMed     Abstract available


  3. GOLDMANN D, Rajan S, Udayakumar K
    Preventing and Controlling Global Antimicrobial Resistance - Implementing a Whole-System Approach.
    N Engl J Med. 2024;391:681-685.
    PubMed    


  4. MAITLAND K, Walker AS
    Why Was the Azithromycin "for Life" Trial Necessary?
    N Engl J Med. 2024;391:760-762.
    PubMed    


    June 2024
  5. LIEBERMAN NAP, Reid TB, Cannon CA, Nunley BE, et al
    Near-Universal Resistance to Macrolides of Treponema pallidum in North America.
    N Engl J Med. 2024;390:2127-2128.
    PubMed    


    May 2024
  6. WAGENLEHNER FM, McGovern PC, Moeck G
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection. Reply.
    N Engl J Med. 2024;390:1938-1939.
    PubMed    


  7. MANESH A, Varghese GM, Paterson DL
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    N Engl J Med. 2024;390:1938.
    PubMed    


  8. VAN OS W, Zeitlinger M
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    N Engl J Med. 2024;390:1937-1938.
    PubMed    


  9. LANINI S, Cai T, Tascini C
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    N Engl J Med. 2024;390:1937.
    PubMed    


    February 2024
  10. WAGENLEHNER FM, Gasink LB, McGovern PC, Moeck G, et al
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    N Engl J Med. 2024;390:611-622.
    PubMed     Abstract available


  11. STRONG N, Meeks G, Sheth SA, McCullough L, et al
    Neurovascular Complications of Iatrogenic Fusarium solani Meningitis.
    N Engl J Med. 2024;390:522-529.
    PubMed     Abstract available


    September 2023
  12. MORELLO W, Baskin E, Jankauskiene A, Yalcinkaya F, et al
    Antibiotic Prophylaxis in Infants with Grade III, IV, or V Vesicoureteral Reflux.
    N Engl J Med. 2023;389:987-997.
    PubMed     Abstract available


    January 2023
  13. BOJKOVA D, Bechtel M, Rothenburger T, Steinhorst K, et al
    Drug Sensitivity of Currently Circulating Mpox Viruses.
    N Engl J Med. 2023;388:279-281.
    PubMed    


    December 2022
  14. NYANG'WA BT, Berry C, Kazounis E, Motta I, et al
    A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
    N Engl J Med. 2022;387:2331-2343.
    PubMed     Abstract available


    May 2022
  15. SEGAL-MAURER S, DeJesus E, Stellbrink HJ, Castagna A, et al
    Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
    N Engl J Med. 2022;386:1793-1803.
    PubMed     Abstract available


    April 2022
  16. ECKBURG PB, Muir L, Critchley IA, Walpole S, et al
    Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection.
    N Engl J Med. 2022;386:1327-1338.
    PubMed     Abstract available


    March 2022
  17. RUBIN EJ, Baden LR, Hunter D, Morrissey S, et al
    Audio Interview: Making Covid-19 Vaccines Available around the World.
    N Engl J Med. 2022;386:e31.
    PubMed    


  18. ROCKETT R, Basile K, Maddocks S, Fong W, et al
    Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use.
    N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMc2120219.
    PubMed    


    February 2022
  19. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 as an Endemic Disease.
    N Engl J Med. 2022;386:e21.
    PubMed    


    January 2022
  20. RUBIN EJ, Baden LR, Barocas JA, Morrissey S, et al
    Audio Interview: Addressing the Omicron Variant of SARS-CoV-2.
    N Engl J Med. 2022;386:e16.
    PubMed    


  21. OMAR SV, Ismail F, Ndjeka N, Kaniga K, et al
    Bedaquiline-Resistant Tuberculosis Associated with Rv0678 Mutations.
    N Engl J Med. 2022;386:93-94.
    PubMed    


  22. JOHN LN, Beiras CG, Houinei W, Medappa M, et al
    Trial of Three Rounds of Mass Azithromycin Administration for Yaws Eradication.
    N Engl J Med. 2022;386:47-56.
    PubMed     Abstract available


    May 2021
  23. HOBERMAN A, Preciado D, Paradise JL, Chi DH, et al
    Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media.
    N Engl J Med. 2021;384:1789-1799.
    PubMed     Abstract available


    April 2021
  24. WANG GL, Wang ZY, Duan LJ, Meng QC, et al
    Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.
    N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103022.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.